Ocugen (OCGN) Interest Coverage Ratio (QoQ) (2014 - 2026)
Ocugen (OCGN) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-5.92% |
| Dec 31, 2025 |
4.88% |
| Mar 31, 2025 |
49.90% |
| Dec 31, 2024 |
94.96% |
| Dec 31, 2021 |
-28.31% |
| Sep 30, 2021 |
55.65% |
| Jun 30, 2021 |
-262.90% |
| Mar 31, 2021 |
-1,438.16% |
| Dec 31, 2020 |
34.21% |
| Sep 30, 2020 |
-156.91% |
| Jun 30, 2020 |
94.82% |
| Mar 31, 2020 |
9.25% |
| Dec 31, 2019 |
-8,367.07% |
| Sep 30, 2019 |
61.71% |
| Jun 30, 2019 |
-27.89% |
| Mar 31, 2019 |
12.49% |
| Dec 31, 2018 |
-231.32% |
| Dec 31, 2016 |
-375.69% |
| Sep 30, 2016 |
28.97% |
| Jun 30, 2016 |
-14.01% |
